Sciclone Pharmaceuticals Inc. Files SEC Form 8-K
Sciclone Pharmaceuticals Inc. has reported a material event to the Securities and Exchange Commission (SEC) in the form of a Form 8-K filing, dated April 6, 2015. As a pharmaceutical company under the SIC code 2834, this filing is a critical document for investors and security holders, providing current information on events that may impact the company's operations or financial status.
Key Takeaways:
- Sciclone Pharmaceuticals Inc. reported a Form 8-K filing with the SEC on April 6, 2015, indicating a material event or corporate change.
- The company's SIC code is 2834, categorizing it as a Pharmaceutical Preparations manufacturer.
- The company is registered at 950 TOWER LANE, SUITE 900, FOSTER CITY CA 94404-2125, with a contact number of 650-358-3456.
- Form 8-K is a "current report" used to report material events or corporate changes that were previously unreported by the registrant.
- This filing provides more current information on specific events than would be included in Forms 10-Q or 10-K.
Statistics:
- SIC code for Sciclone Pharmaceuticals Inc.: 2834
- Date of SEC Form 8-K filing: April 6, 2015
- Number of documents filed with this form: 1
- SEC file number: 0001193125-15-119990
- Contact information for the company: 950 TOWER LANE, SUITE 900, FOSTER CITY CA 94404-2125, 650-358-3456
Sources:
- NewsRx LLC (2015) - NewsReporter-Staff News Editor
- U.S. Securities and Exchange Commission (2015) – Form 8-K (0001193125-15-119990)